KOLMAR BNH BROADENS INTERNATIONAL PRESENCE VIA HEMOHIM G LAUNCHING IN TAIWAN

Manufactured by Kolmar BNH and distributed by Atomy, HemoHIM G, containing Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora, is now available in Taiwan. (Photo: Kolmar BNH) 

SEOUL, South Korea, May 29 (Bernama) -- Kolmar BNH (KRX: 200130), a prominent Korean health functional food Original Development Manufacturing (ODM) firm, announced that it has unveiled its latest offering, HemoHIM G, in Taiwan. This introduction is part of the company's endeavor to expand its presence in global markets.

HemoHIM G represents an enhanced iteration of HemoHIM, tailored to meet the distinctive tastes of consumers in Taiwan and Europe.

Kolmar BNH plans to expedite its market expansion in Asia by launching HemoHIM G in the Taiwan market on May 15. HemoHIM G, tailored for international export, has made meticulous adjustments in raw materials and ingredient proportions to comply with varying food regulations across different jurisdictions. Key ingredients such as Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora went through rigorous sourcing procedures, accompanied by stringent quality control measures. The taste and aroma profiles were tailored to suit the preferences of European consumers.

For full release, click here : http://mrem.bernama.com/viewsm.php?idm=48688